Home/Isofol Medical/Sebastian Stintzing

SS

Sebastian Stintzing

Principal Coordinating Investigator (External KOL)

Therapeutic Areas

Oncology Neurology

Isofol Medical Pipeline

Drug	Indication	Phase
Arfolitixorin	Metastatic Colorectal Cancer (mCRC)	Phase Ib/II

Leadership Team at Isofol Medical

Petter Segelman Lindqvist

Chief Executive Officer

View full Isofol Medical profile